Introduction
In mammalian cells progression from G1 into S phase requires the activity of the cyclin-dependent kinases Cdk4 and Cdk2. Activation of these Cdks is regulated by multiple mechanisms including binding of the G1 cyclins, the state of phosphorylation, and the presence or absence of cyclin-dependent kinase inhibitors (CKIs). The CKI p27
Kip1 appears to be particularly important for regulation of normal cell cycle progression. Contact inhibition , serum deprivation (Coats et al., 1996) , inhibitory factors such as transforming growth factor-b (TGF-b; Polyak et al., 1994; Ravitz et al., 1995; Kamesaki et al., 1998) and cAMP Friessen et al., 1997) lead to elevated cellular levels of p27 Kip1 and subsequent cell cycle arrest. In contrast, mitogenic activation of cells leads to a decline in the level of p27 Kip1 allowing Cdk activation and entry into S phase (Nourse et al., 1994; Winston et al., 1996; Rivard et al., 1996) . The levels of p27
Kip1 are known to be regulated by the rate of synthesis (Hengst and Reed, 1996; Agrawal et al., 1996; Millard et al., 1997) , by proteasomal targeting and degradation (Pagano et al., 1995) , and by transcriptional control (Johnson et al., 1998; Moro et al., 1998) . In addition, recent experiments suggest that the subcellular location of p27
Kip1 may be an important factor in determining its ability to inhibit cell cycle progression. Singh et al. (1998) found that cytoplasmic localization of p27
Kip1 was associated with aggressive behavior of certain epithelial tumors. Similarly, the data of Orend et al. (1998) suggest that cytosolic localization of p27
Kip1 is associated with an anchorageindependent phenotype in cultured cells.
In the present study, we examined the subcellular localization of p27
Kip1 in 3T3 cells, as well as in several other cultured cell lines. We observed that endogenous p27
Kip1 is located exclusively in the cytosol in both quiescent and serum stimulated 3T3 cells. Following serum stimulation the amount of cytosolic p27 Kip1 decreased markedly and at the same time the levels of both Cdk2 and cyclin E increased in the nuclear fraction. Cdk2 from the cytosolic fraction of serum stimulated cells was active. In contrast Cdk2 from the cytosolic fraction of quiescent cells was associated with p27
Kip1 and inactive. In other cell lines p27 Kip1 was observed in both the cytosolic and nuclear compartments, although the highest level was always observed in the cytosol. Overexpression of p27
Kip1 in 3T3 cells inhibited uptake of Cdk2 into the nucleus following serum stimulation. These results suggest that p27 Kip1 localized to the cytosol can aect both the activity and subcellular localization of Cdk2.
Results
Quiescent Swiss/3T3 ®broblasts were stimulated with serum for various times over a 15 h time course. The cells were lysed and fractionated into cytosolic and nuclear components and these fractions were analysed by Western blotting. To estimate the eciency of the fractionation procedure, the p85 regulatory subunit of phosphatidylinositol-3 kinase was used as a cytosolic marker and the transcription factors Sp1 andATF-1 were used as nuclear markers. As expected, p85 was found only in the cytoplasmic fractions ( Figure 1a ). Both ATF-1 and Sp1 (Figure 1b and c respectively) were found predominantly in the nuclear fractions. A low level of Sp1 was found in the cytosol in quiescent cells but not after serum stimulation for 9 ± 15 h. These results indicate that the fractionation procedure utilized eciently separates nuclear components from cytosolic components.
The levels of the cyclin-dependent kinase inhibitor p27 Kip1 in the subcellular fractions obtained from quiescent cells or at various times after serum stimulation were also analysed by Western blotting (Figure 1d ). Consistent with previous reports (Agrawal et al., 1996), p27 Kip1 was expressed at high levels in quiescent 3T3 cells but gradually declined to very low levels by 12 ± 15 h after serum stimulation, the time at which the cells are entering into S phase (Ouyang et al., 1993) . Surprisingly, however, no p27
Kip1 was detected in the nuclear fraction at any time point. This was true even with quiescent unstimulated cells which express high levels of the inhibitor. It should be noted that the same extract preparations were used for the experiments shown in Figure 1c and d.
Although the marker proteins indicate ecient separation of cytosolic and nuclear fractions, the use of detergent in the lysis buer may result in leakage of nuclear proteins into the cytoplasmic fraction. Therefore, the results were con®rmed using two additional methods. The ®rst method was used by Orend et al. (1998) to analyse p27
Kip1 localization in a variety of cell types. This method uses mechanical disruption following hypotonic cell swelling. The second method is an extremely ecient but gentle method using an isotonic buer that destabilizes the plasma membrane but does not disrupt any of the intracellular organelles (Miskimins and Shimizu, 1982) . Using both of these procedures p27
Kip1 was also exclusively associated with the cytoplasmic fraction in quiescent 3T3 cells ( Figure  1e) . The subcellular fractionation experiments described above were further con®rmed using immunofluorescence to detect p27
Kip1 in Swiss/3T3 cells that were quiescent (Figure 2a ) or that had been serum stimulated for 17 h (Figure 2b ). In the quiescent cells uorescence was detected in the cytosol but appeared to be excluded from the nucleus. A similar pattern of staining was detected in cells that had been serum stimulated for 17 h, except that the¯uorescence was much weaker. As a control experiment, immunofluorescence analysis was performed using antibodies to Sp1 with cells that were ®xed and permeabilized using the same procedure ( Figure 2c ). As expected, Sp1 is detected in the nucleus, indicating that the failure to detect p27
Kip1 in the nucleus is not due to inaccessibility of the antibody to this compartment.
An important target of p27 Kip1 is the cyclin E-Cdk2 complex. Therefore it was of interest to compare the subcellular localization of these proteins in serum stimulated 3T3 cells to that of p27 Kip1 . A substantial level of cyclin E was observed in the cytoplasmic fraction at all time points (Figure 3a) . In contrast, cyclin E in the nuclear fraction increased with time after serum stimulation, reaching the highest level 12 ± 15 h after stimulation. The pattern observed for Cdk2 was nearly identical to that observed for cyclin E (Figure 3b ). It is interesting to note that the increase in nuclear levels of cyclin E and Cdk2 corresponds in time with the lowest levels of p27
Kip1 in the cytosol and the transition from G1 into S phase of the cell cycle. Kip1 in Swiss/3T3 cells. Con¯uent, quiescent cells were stimulated with serum for the time (h) indicated above each lane. The cells were harvested and nuclear (N) and cytosolic (C) fractions were isolated using a detergent lysis method (see Materials and methods). The fractions were then analysed by Western blotting for PI3 kinase (a), ATF-1 (b), Sp1 (c) and p27 Kip1 (d) . (e) Two additional methods, as indicated at the top, were used to isolate nuclear and cytosolic fractions from quiescent Swiss/3T3 cells as described in the text and in Materials and methods From the results above it appears that p27 Kip1 , cyclin E, and Cdk2 co-localize to the cytosol in quiescent Swiss/3T3 cells. Furthermore, in serum stimulated cells cyclin E and Cdk2 only reach signi®cant levels in the nucleus after p27
Kip1 is down regulated. Therefore, it was of interest to determine the activity of cytosolic and nuclear Cdk2 and its association with p27 Kip1 . Quiescent or serum stimulated Swiss/3T3 cells were lysed and fractionated into cytosolic and nuclear fractions as described above. Cdk2 was then immunoprecipitated from each fraction and analysed for kinase activity and p27
Kip1 co-precipitation ( Figure 4 ). In the cytosolic fraction from quiescent cells Cdk2 was inactive and co-precipitated with p27
Kip1 . After 15 h of serum stimulation, Cdk2 activity immunoprecipitated from the cytosol was highly elevated. This corresponded to a large decline in p27 Kip1 coprecipitation and an increase in the level of Cdk2 protein. Cdk2 activity in the nucleus was only observed after serum stimulation. Cdk2 in the nuclear compartment did not co-precipitate with detectable p27 Kip1 in either quiescent or serum-stimulated cells. Kip1 in cytosolic and nuclear fractions from Swiss/3T3 cells. Quiescent cells (0) or cells that had been serum stimulated for 15 h were lysed and separated into nuclear (N) and cytosolic (C) fractions. Anti-Cdk2 antibodies were used to immunoprecipitate Cdk2. Half of the sample was used to assay Cdk2 kinase activity using histone H1 as a substrate (top panel). The other half of the sample was used for Western blotting to detect p27 Kip1 (middle panel) or Cdk2 (bottom panel)
A possible explanation for the results above is that association of p27
Kip1 with the Cdk2/cyclin E complex in the cytosol prevents nuclear localization of all of these proteins. If so, forced overexpression of p27
Kip1 in 3T3 cells should allow the levels of the inhibitor to exceed that of Cdk2/cyclin E resulting in nuclear accumulation of p27 Kip1 . To test this the LAP3-p27 cell line was utilized (Shiyanov et al., 1997) . This line is a derivative of NIH3T3 in which p27
Kip1 is induced to high levels by the addition of isopropyl-1-thio-b-Dgalactopyranoside (IPTG). These cells were grown to con¯uence and allowed to become quiescent. They were then treated with or without IPTG in the presence or absence of serum. As with Swiss/3T3, elevated levels of p27
Kip1 were observed in quiescent cells and the inhibitor was localized almost exclusively to the cytosol ( Figure 5 ). p27 Kip1 than in quiescent cells and a signi®cant level of the inhibitor was associated with the nucleus. Overexpression of p27 Kip1 had no eect on the levels of Cdk2 but did block nuclear accumulation of the kinase in serum stimulated cells. Unexpectedly, overexpression of p27 Kip1 in serum stimulated cells was accompanied by elevated levels of cyclin E resulting in an altered ratio of cyclin E to Cdk2. Under these conditions there was some increase in nuclear cyclin E. Overexpression of p27
Kip1 had no eect on the levels or localization of marker proteins for the nuclear and cytoplasmic fractions (Figure 5b ).
In order to determine if the cytosolic localization of p27 Kip1 was unique to 3T3 cells, the subcellular localization of p27
Kip1 was also analysed in several other cultured cell lines (Figure 6a ). The cell lines used were derived from various tissues and species and included a human tumor line (HeLa), a mouse liver tumor (Hepa-1), a normal rat ®broblast (Rat-1) and a normal mink lung epithelial line (Mv1Lu). In all of these lines the bulk of p27
Kip1 was found in the cytoplasmic fraction. However, a signi®cant quantity of p27
Kip1 was detected in the nuclear fraction for Mv1Lu, Rat-1, and HeLa cells. For Mv1Lu this result was con®rmed by immuno¯uorescence (Figure 6b) . The Kip1 and Sp1 as indicated strongest signal was observed in the cytosol but ā uorescent signal was also detected within the nuclei. Interestingly, p27
Kip1 appears to be localized to certain regions of the nuclei in this cell line. For Hepa-1 mouse liver tumor cells no p27
Kip1 was detected in the nuclear fraction, similar to the results for Swiss/3T3. All of these are immortal cell lines or lines established from tumors. Therefore we tested a primary, unpassaged culture of mixed glial cells derived from newborn rat brains. In these cells p27
Kip1 was detected only in the nuclear fraction (Figure 6c ).
Discussion
We have shown that quiescent, contact inhibited Swiss/ 3T3 cells express a high level of p27
Kip1 which is localized exclusively to the cytosol. In addition, the quiescent cells express signi®cant levels of Cdk2 which is also found in the cytosolic fraction, is inactive, and co-immunoprecipitates with p27
Kip1
. Following serum stimulation p27 Kip1 remains associated with the cytosolic fraction but is down regulated to very low levels. Down regulation of p27 Kip1 correlates with uptake of Cdk2 and cyclin E into the nucleus. Nuclear Cdk2 is not associated with p27
Kip1 and is highly active as a kinase. Active Cdk2 is also found in the cytosolic fraction isolated from serum stimulated cells.
These results suggest that in quiescent 3T3 cells a complex involving Cdk2, cyclin E, and p27 Kip1 is retained in the cytosol. Mitogenic activation leads to turnover of p27 Kip1 allowing the cyclin E/Cdk2 complex to become active and be transported into the nucleus. Such a model is clearly not applicable to all cells and the localization of p27 Kip1 is highly variable between cell lines. For several of the cell lines that we analysed at least a portion of the p27 Kip1 is found in the nucleus. Orend et al. (1998) have also observed variability in the localization of p27 Kip1 between cell lines. In their study they observed a correlation between cytosolic localization of the inhibitor and anchorage-independent growth. In contrast, they found that in anchorage-dependent normal human ®broblasts p27
Kip1 is localized exclusively to the nucleus. They also observed that a signi®cant proportion of cyclin E and Cdk2 was localized to the cytosol in the anchorage-independent tumor cell lines. This suggested that cytosolic cyclin E/ Cdk2 complexes sequester p27
Kip1 and prevent it from inhibiting nuclear cyclin E/Cdk2 activity. It is possible that a similar mechanism anchors p27 Kip1 in the cytosol of 3T3 cells. However, this cell line is not transformed, is anchorage-dependent, and is contact inhibited.
Based on experiments using TGF-b treated Mv1Lu cells Reynisdottir and Massague (1997) have proposed a model in which the CKI p15
Ink4b prevents p27 Kip1 from binding to Cdk4, thereby promoting binding of p27 Kip1 to Cdk2. In this way the two CKIs can coordinate inhibition of both Cdk4 and Cdk2. However, subcellular localization plays a critical role in this mechanism since p15 must have prior acess to Cdk4 to block p27
Kip1 binding (Reynisdottir and Massague, 1997) . This is the situation that exists if p15 is localized to the cytosol and p27
Kip1 is localized to the nucleus. Clearly, such a mechanism is not feasible in cells in which p27
Kip1 is localized primarily to the cytosol.
What can account for the observed variability in localization of p27 Kip1 ? One simple model is that formation of a cytosolic complex between p27
Kip1 and cyclin E/Cdk2 blocks nuclear transport of either component. Thus coordinate synthesis of all components of the complex would lead to retention in the cytosol. Down regulation of p27
Kip1 in response to mitogenic activation, as observed in 3T3 cells, would allow nuclear transport of cyclin E/Cdk2 complexes. To test this model we used the LAP3-p27 cell line in which p27
Kip1 is overexpressed in response to IPTG. Overexpression resulted in nuclear accumulation of p27 Kip1 . This suggests that the levels of p27
Kip1 exceeded those of Cdk2/cyclin E allowing it to be imported into the nucleus. In addition, overexpression of p27 Kip1 in serum stimulated cells inhibited accumulation of Cdk2 in the nucleus. These results further indicate that cytosolic complexes of Cdk2/cyclin E and p27
Kip1 cannot be transported into the nucleus. A very interesting ®nding is that induction of high levels of p27
Kip1 in serum stimulated cells also resulted in highly elevated levels of cyclin E but had no eect on Cdk2 levels. Under these conditions there would exist an imbalance between Cdk2 and cyclin E levels, resulting in free cyclin E that can be transported to the nucleus. The mechanism by which elevated p27
Kip1 leads to cyclin E accumulation is unknown but must involve post-transcriptional regulation because Shiyanov et al. (1997) demonstrated that cyclin E mRNA levels do not change signi®cantly under these conditions.
Together our results indicate that expression of levels of cyclin E/Cdk2 complexes, above that of p27 Kip1 , leads to nuclear localization of a portion of the kinase complex. Likewise, elevated expression of p27 Kip1 , above that of cyclin E/Cdk2 complexes, leads to partial nuclear localization of the inhibitor. Thus the ratio of p27
Kip1 to cyclin E/Cdk2 would determine the nuclear content of either, and explain the variability in localization that has been observed by us and others (Orend et al., 1998) . In normal, non-immortal, nontransformed cells such as primary cell cultures p27 Kip1 and cyclin E/Cdk2 complexes are not expected to be synthesized coordinately. p27
Kip1 is expected to be produced under conditions that promote quiescence such as contact inhibition or dierentiation while cyclin E is expected to be synthesized in proliferating cells in late G1 of the cell cycle. Thus, we would expect p27 Kip1 and cyclin E/Cdk2 complexes both to be localized to the nucleus in such cells and this is what has been observed for cultured human ®broblasts by Orend et al. (1998) . Likewise in our experiments using primary rat glial cells p27
Kip1 was localized to the nucleus.
The importance of p27
Kip1 localization is further demonstrated by the recent ®ndings of Soucek et al. (1998) . These investigators reported that loss of the tumor suppressor gene TSC2 resulted in cytoplasmic rather than nuclear localization of p27 Kip1 . In Swiss/3T3 cells we have been able to detect tuberin, the product of the TSC2 gene, by Western blotting. Therefore it is unlikely that lack of TSC2 gene expression is the reason for cytoplasmic localization in these cells. Additional factors such as phosphorylation status and additional protein-protein interactions may aect localization of p27 Kip1 and cyclin E/Cdk2 complexes.
However, considering that cyclin E/Cdk2 activity is elevated in many transformed and tumorigenic cells, that a decline in p27
Kip1 expression is strongly correlated with poor prognosis for many types of cancer, and that altered subcellular localization of p27
Kip1 is associated with aggressive behavior of some tumors (Catzavelos et al., 1997; Loda et al., 1997; Fredersdorf et al., 1997; Mori et al., 1997) , it will be very important to understand the mechanisms which in¯uence subcellular targeting of these factors.
Materials and methods

Cell lines and culture conditions
Swiss/3T3 and HeLa cell lines were obtained from ATCC. Rat-1 and Mv1Lu cells were a gift of L Kretzner, Hepa-1 cells were a gift of Oliver Hankinson and LAP3-p27 cells were a gift of Pradip Raychaudhuri. All cell lines except Mv1Lu cells were grown in Dulbecco's Modi®ed Eagle's Medium (DMEM) containing 10% calf serum, 100 U/ml penicillin and 100 mg/ml streptomycin at 378C in a humidi®ed atmosphere containing 5% CO 2 . Mv1Lu cells were grown under the same conditions except that fetal calf serum was used.
Subcellular fractionation
Swiss/3T3 cells were grown in 100 mm dishes until con¯uent. They were then incubated in a 1 : 1 mixture of Waymouth's medium and DMEM for 48 h. The cells were stimulated with 20% calf serum for 6, 9, 12 or 15 h. The cells were harvested by scraping them in the culture medium followed by centrifugation in an IEC HN-SII at 1000 r.p.m. for 10 min. The cell pellets were washed twice with Dulbecco's phosphate buered saline. After the last wash, the cell pellets were resuspended in 150 ml cold lysis buer [10 mM HEPES (pH 7.9), 1.5 mM Mg/Cl 2 , 10 mM KCl, 300 mM sucrose, 1 mM EDTA, 1 mM DTT, 0.1 mM Na 3 VO 2 , 0.1% Triton X-100, 1 mg/ml leupeptin and 1 mg/ml aprotinin]. After standing on ice for 1 h the lysate was centrifuged in an Eppendorf 5415c microcentrifuge for 10 min at 48C at 3300 r.p.m. The supernatant containing the cytoplasmic fraction was removed and the nuclear pellet was washed twice in 1 ml lysis buer. After the ®nal wash, the nuclear pellet was resuspended in 50 ml 26SDS-sample buer [5% SDS, 5 mM Tris-Cl (pH 6.8), 200 mM DTT, 20% glycerol, 0.05% pyronine Y]. The samples were then sonicated, centrifuged at full speed in an Eppendorf microcentrifuge for 10 min, and mixed with an equal volume of lysis buer. The cytoplasmic fraction was mixed with an equal volume of 26SDS-sample buer.
Cell lysis and fractionation using hypotonic buer was carried out by a method similar to that published by Orend et al. (1998) . Cells were incubated in hypotonic buer [1.5 mM MgCl 2 , 10 mM HEPES (pH 7.9), 10 mM KCl, 0.5 mM DTT, 10 mg/ml leupeptin, 0.1 U/ml aprotinin] on ice for 30 min. The cells were then disrupted by 20 strokes in a Dounce homogenizer. Nuclear and cytosolic fractions were separated by the procedure described above.
Isotonic cell lysis using SEAT buer was performed as previously described (Miskimins and Shimizu, 1982) .
Western blotting
Identical volumes of nuclear or cytosolic extracts from the various time points were loaded on a 10% SDS ± PAGE gel. After electrophoresis proteins were transferred from the gel to Immobilon P (Millipore) membranes using a semidry transfer apparatus. The membrane was blocked with 5% non-fat dry milk in Tris-buered saline [10 mM Tris-Cl (pH 7.5), 150 mM NaCl] containing 0.1% Tween-20 (TBS-T) for 1 h at room temperature. The membrane was then incubated with the appropriate antibody in TBS-T containing 5% non-fat dry milk for 1 h at room temperature. After extensive washing in TBS-T the membrane was incubated with the appropriate horseradish peroxidase-conjugated secondary antibody. After extensive washing in TBS-T, proteins were detected using the SuperSignal chemiluminescence system (Pierce Chemical Co.).
Immuno¯uorescence analysis
Cells were grown on cover slips until con¯uent and serum starved as described above. The cells were either left unstimulated or stimulated with 20% calf serum for 17 h. The cells were washed twice with cold PBS, ®xed in 50% methanol plus 50% acetone for 10 min at 7208C, and air dried at room temperature. The ®xed cells were then incubated in PBS containing 0.1% Triton X-100 for 30 min at room temperature and blocked with 10% goat serum in PBS for 1 h. They were then washed once with PBS and incubated with anti-p27
Kip1 or anti-Sp1 (1 : 50 dilution of each) for 40 min in PBS containing 0.1% Triton X-100 and 2% BSA. The cover slips were washed in PBS containing 0.1% Triton X-100 six times for 5 min with shaking. The cells were then incubated with anti-rabbit IgG conjugated wth FITC in PBS containing 0.1% Triton X-100 and 2% BSA for 40 min. After washing, the coverslips were mounted on slides with Fluoroguard (BioRad) and visualized using a Zeiss Axiovert 35 microscope.
Immunoprecipitation kinase assay of Cdk2
This assay was carried out exactly as described by Friessen et al. (1997) . The immunoprecipitate was divided into two parts. Half was used for the Cdk2 kinase assay and half was used for Western blotting.
Antibodies
The following antibodies were purchased from Santa Cruz Biotechnology: polyclonal anti-p27
Kip1 (M-197) , anti-cyclinE (M-20), anti-ATF-1 (C41-5.1), anti-Sp1 (PEP2), and antiCdk2 (M2). Anti-PI3-kinase (p85) and monoclonal antip27
Kip1 were purchased from Transduction Laboratories.
